Ccu106 发表于 2025-3-28 16:33:31
http://reply.papertrans.cn/29/2831/283087/283087_41.pngpropose 发表于 2025-3-28 19:02:39
Glycopeptides and Antibiotics for Gram-positive Bacterial Infections,ns caused by Gram-positive bacteria. Limited information is available about the dosing of these antibiotics in obese patients. This chapter aims to summarise the available evidence on the dosing of glycopeptides, lipopeptides, linezolid and quinupristin/dalfopristin in obesity. Specific dosing recomSTAT 发表于 2025-3-29 02:56:14
Azole Antifungal Agents,gement of systemic fungal infections. Their application in the prophylaxis against and treatment of systemic mycoses continues to evolve, with ongoing advancements in drug delivery, efficacy, monitoring and side effect profiling. Pharmacokinetic changes and dose guidance for these agents in the obesCatheter 发表于 2025-3-29 05:10:52
http://reply.papertrans.cn/29/2831/283087/283087_44.pngInterdict 发表于 2025-3-29 09:27:52
http://reply.papertrans.cn/29/2831/283087/283087_45.png远地点 发表于 2025-3-29 13:30:14
http://reply.papertrans.cn/29/2831/283087/283087_46.png尾巴 发表于 2025-3-29 15:35:02
Book 2016ng up-to-date information on antimicrobial dosing in obese patients. Doctors, pharmacists, nurses working in hospital settings, and students of health courses (medical, pharmacy and nursing students) will find this book particularly useful..蚀刻术 发表于 2025-3-29 20:09:40
http://reply.papertrans.cn/29/2831/283087/283087_48.pngintertwine 发表于 2025-3-30 02:56:53
http://reply.papertrans.cn/29/2831/283087/283087_49.png